Detailed information for compound 931927

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 482.418 | Formula: C24H30Cl2FN3O2
  • H donors: 0 H acceptors: 1 LogP: 4.83 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1ccc(cc1)C1CC(c2c1cccc2)N1CCN(CC1)CCN1CCOC1=O.Cl.Cl
  • InChi: 1S/C24H28FN3O2.2ClH/c25-19-7-5-18(6-8-19)22-17-23(21-4-2-1-3-20(21)22)27-12-9-26(10-13-27)11-14-28-15-16-30-24(28)29;;/h1-8,22-23H,9-17H2;2*1H
  • InChiKey: RPMOXKBXUPKWAX-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Serotonin 2 (5-HT2) receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus g protein coupled receptor Serotonin 2 (5-HT2) receptor   460 aa 412 aa 19.7 %
Echinococcus multilocularis neuropeptides capa receptor Serotonin 2 (5-HT2) receptor   460 aa 408 aa 20.8 %
Echinococcus multilocularis g protein coupled receptor Serotonin 2 (5-HT2) receptor   460 aa 412 aa 19.9 %
Loa Loa (eye worm) hypothetical protein Serotonin 2 (5-HT2) receptor   460 aa 417 aa 21.3 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Serotonin 2 (5-HT2) receptor   460 aa 405 aa 31.1 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Serotonin 2 (5-HT2) receptor   460 aa 427 aa 28.3 %
Echinococcus multilocularis g protein coupled receptor Serotonin 2 (5-HT2) receptor   460 aa 409 aa 21.5 %
Echinococcus granulosus g protein coupled receptor Serotonin 2 (5-HT2) receptor   460 aa 409 aa 21.8 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Entamoeba histolytica fatty acid elongase, putative 0.0258 0 0.5
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.1987 1 0.5
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.1987 1 0.5
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.1987 1 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0258 0 0.5
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.1987 1 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0258 0 0.5
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.1987 1 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0258 0 0.5
Entamoeba histolytica fatty acid elongase, putative 0.0258 0 0.5
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.1987 1 0.5
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.1987 1 0.5

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) > 83 uM kg-1 Inhibition of methyl phenidate induced stereotyped gnawing in mice ChEMBL. 2903929
IC50 (binding) = 130 nM Inhibition of [3H]-spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes ChEMBL. 2903929

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.